FindTrial
Sign In

A study to assess the improvment of Rheumatoid Arthritis by Neikkuri (siddha Diagnostic tool)

A cross sectional study to assess the prognosis of Rheumatoid Arthritis patients treated with siddha medicine through Neikkuri at Ayothidoss Pandithar Hospital, National Institute Of Siddha. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/057345
Enrollment
62
Registered
2023-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are willing to sign consent form Patients diagnosed with Rheumatoid Arthritis with EULAR score

Exclusion criteria

Exclusion criteria: Patients with mental illness vulnerable group

Design outcomes

Primary

MeasureTime frame
Documentation of Neikkuri changes in Uthiravathasuronitham (Rheumatoid Arthritis)Timepoint: Base line: 0 day End point: 48th day—

Secondary

MeasureTime frame
Documentation of the prognosis of Uthiravathasuronitham (Rheumatoid Arthritis) through Neikkuri by periodic assessment & based on reduction in EULAR criteria & MHAQ (Modified Health Assessment Score questionnaire) score from base line to end point in each patientTimepoint: Base Line 0 DAY End point 48TH DAY—

Countries

India

Contacts

Public ContactDr M Ramamurthy

NATIONAL INSTITUTE OF SIDDHA

ramsnis@gmail.com9443178112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026